Imgatuzumab

Imgatuzumab
Monoclonal antibody
TypeWhole antibody
SourceHumanized (from rat)
TargetEGFR
Clinical data
ATC code
  • none
Identifiers
CAS Number
ChemSpider
  • none
UNII
KEGG
Chemical and physical data
FormulaC6434H9942N1718O2016S44
Molar mass145028.96 g·mol−1

Imgatuzumab (INN) is a humanized monoclonal antibody designed for the treatment of cancer. It is an anti-EGFR antibody that acts as an immunomodulator.

The drug was developed by Genentech/Roche.

This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.